Related Research Articles
Investor AB is a Swedish investment and holding company, often considered a de facto conglomerate. One of Sweden's largest companies, Investor AB serves as the investment arm of the prominent Swedish Wallenberg family; the family's companies are involved in a variety of industries, of which the primary industries are pharmaceuticals, telecommunications and industry.
A biopharmaceutical, also known as a biological medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, whole blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living medicines used in cell therapy. Biologics can be composed of sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living cells or tissues. They are isolated from living sources—human, animal, plant, fungal, or microbial. They can be used in both human and animal medicine.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company, based in Pune. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.
Grifols, S.A. is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma–based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories.
Lexington Partners is one of the largest manager of secondary acquisition and co-Investment funds in the world, founded in 1994. Lexington manages approximately $55 billion of which an unprecedented $14 billion was committed to the firm's ninth fund, the largest dedicated secondaries pool of capital ever raised at the time.
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
China has seen double-digit growth in its biotechnology industry and has gone from being one of the slowest to one of the fastest nations in the adoption of new biotechnologies. The biotech sector is seen in China and internationally as a core area of national scientific and economic development. The main national biotech body in the country is the China National Center for Biotechnology Development. The CNCBD is an organization established on November 3, 1983, under the Ministry of Science and Technology with the approval of the State Council. CNCBD is the sole national center to coordinate and implement the national S&T program in Biotechnology and Health.
Acuris is a financial news and data firm known for its products fixed income research provider Debtwire and Mergermarket, a specialist in M&A intelligence. It is owned by ION Investment Group, a financial software and data business which owns Fidessa and Dealogic. ION Group bought the company from BC Partners, a private equity group, and GIC Private Limited, Singapore's sovereign wealth fund, in 2019.
Bio Products Laboratory Limited (BPL) is a company involved in the manufacture of human blood plasma products, located in Elstree, Hertfordshire, England. It is run as a commercial business and supplies plasma derived products to the National Health Service in the UK as well as to markets in over 45 countries.
GC Biopharma [Green Cross Corporation] is a biopharmaceutical company headquartered in Yongin, South Korea.
Quadria Capital is an independent healthcare focused private equity firm that specializes in growth capital investments in small cap and middle-market companies within the healthcare sector across South and Southeast Asia.
Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.
Canadian Plasma Resources (CPR) is a private, for-profit bio-pharmaceutical company and a licensed blood establishment based in Saskatoon, Saskatchewan, Canada. It was founded in 2012 and specializes in the collection of source plasma for further manufacturing and contract-manufacturing of plasma-based bio-pharmaceuticals with operations in Saskatoon (Saskatchewan), Moncton, Calgary, Edmonton (Alberta), Winnipeg (Manitoba) and administrative office in Oakville, Ontario. CPR is one of the only four establishments in Canada that are licensed to collect plasma. The others are Canadian Blood Services (CBS), Hema-Quebec and Cangene, now owned by ProMetic Life Sciences Inc.
The US carries out 46% of global research and development (R&D) in the life sciences, making it the world leader in medical research.
The Creat Group is a Chinese investment firm based in Beijing incorporated in 1992. It has expertise in the plasma industry and invests in healthcare and pharmaceuticals, manufacturing, energy, finance, natural resources, and real estate.
Biopharma is the Ukrainian pharmaceutical company focused on the development and production of drugs based on human plasma.
EQT Private Capital Asia (formerly known as Baring Private Equity Asia, BPEA and BPEA EQT) is an Asian investment firm headquartered in Hong Kong. It was founded in 1997 as an affiliate of Barings Bank before becoming an independent firm in 2000. In 2022, it was acquired by EQT AB to act as its Asian investment platform. EQT Private Capital Asia is one of the largest private equity firms in Asia.
Gaorong Capital is a Beijing-based venture capital firm founded in 2014. The firm focuses on investments related to Technology, Media and Telecommunications (TMT).
CBC Group is an Asian investment firm headquartered in Singapore. It is focused on private investments in the healthcare and biotechnology industries. It is considered the largest healthcare-focused investment firm in Asia.
References
- ↑ "PE investors complete $4.6b China Biologic take-private | AVCJ". AVCJ. 2021-04-22. Retrieved 2023-12-30.